4007 GMB

Holly Ingraham, PhD will speak on Nuclear Receptor Signaling in Hepatic Lipid Remodeling and Intestinal Resilience. Dr. Ingraham is Professor and Associate Vice Chair, Cellular and Molecular Pharmacology, and Herzstein Distinguished Investigator at UCSF.

Andrew Hopkins ('The Druggable Genome'; University of Dundee)